RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Undaria pinnatifida Inhibits the Mast Cell-Mediated Inflammatory Response via NF-κB/Caspase-1 Suppression

      한글로보기

      https://www.riss.kr/link?id=A107964803

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Marine sources as potential treatment options for various diseases have been a subject of growing interest. However, information on the anti-inflammatory mechanism employed by Undaria pinnatifida (UP) remains limited. The present study was conducted t...

      Marine sources as potential treatment options for various diseases have been a subject of growing interest. However, information on the anti-inflammatory mechanism employed by Undaria pinnatifida (UP) remains limited. The present study was conducted to investigate the mechanisms of UP on the mast cell-mediated inflammatory response. To determine the pharmacological mechanism of UP in inflammatory reaction, we evaluated the effects of UP on interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF)-α production and nuclear factor-κB (NF-κB) and caspase-1 activation in calcium ionophore A23187 plus phorbol 12-myristate 13-acetate-stimulated human mast cells-1 (HMC-1). The results showed that UP suppressed IL-6, IL-8 and TNF-α production in a dose-dependent manner. Moreover, UP significantly attenuated NF-kB/caspase-1 activation in stimulated HMC-1. Collectively, these findings provide experimental evidence that UP may be a useful candidate for the inflammation-related diseases treatment.

      더보기

      목차 (Table of Contents)

      • Introduction Materials and Methods Results Discussion Acknowledgements Conflicts of Interest References
      • Introduction Materials and Methods Results Discussion Acknowledgements Conflicts of Interest References
      더보기

      참고문헌 (Reference)

      1 유주형, "금화규(Abelmoschus manihot) 뿌리 추출물의 면역증진 및 항비만효과" 한국자원식물학회 34 (34): 411-419, 2021

      2 Etman, S. M., "Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer" 170 : 284-297, 2021

      3 이환희, "Undaria pinnatifida Fucoidan-Rich Extract Recovers Immunity of Immunosuppressed Mice" 한국미생물·생명공학회 30 (30): 439-447, 2020

      4 Kim, S. J., "T he beneficial effect of vanillic acid on ulcerative colitis" 15 : 7208-7217, 2010

      5 Han, N. R., "Schisandra chinensis and its main constituent schizandrin attenuate allergic reactions by downregulating caspase-1 in ovalbumin-sensitized mice" 45 : 159-172, 2017

      6 정지욱, "Ribes fasciculatum var. chinense Attenuated Allergic Inflammation In Vivo and In Vitro" 한국응용약물학회 22 (22): 547-552, 2014

      7 Yao, C, "Prostaglandin‐cytokine crosstalk in chronic inflammation" 176 (176): 337-354, 2019

      8 Kimur, J, "New loliolide derivatives from the brown alga Undaria pinnatifida" 65 : 57-58, 2002

      9 Tak, P. P., "NF-κB : A key role in inflammatory disease" 107 : 7-11, 2001

      10 Olivera, A., "Mast cells signal their importance in health and disease" 142 : 381-393, 2018

      1 유주형, "금화규(Abelmoschus manihot) 뿌리 추출물의 면역증진 및 항비만효과" 한국자원식물학회 34 (34): 411-419, 2021

      2 Etman, S. M., "Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer" 170 : 284-297, 2021

      3 이환희, "Undaria pinnatifida Fucoidan-Rich Extract Recovers Immunity of Immunosuppressed Mice" 한국미생물·생명공학회 30 (30): 439-447, 2020

      4 Kim, S. J., "T he beneficial effect of vanillic acid on ulcerative colitis" 15 : 7208-7217, 2010

      5 Han, N. R., "Schisandra chinensis and its main constituent schizandrin attenuate allergic reactions by downregulating caspase-1 in ovalbumin-sensitized mice" 45 : 159-172, 2017

      6 정지욱, "Ribes fasciculatum var. chinense Attenuated Allergic Inflammation In Vivo and In Vitro" 한국응용약물학회 22 (22): 547-552, 2014

      7 Yao, C, "Prostaglandin‐cytokine crosstalk in chronic inflammation" 176 (176): 337-354, 2019

      8 Kimur, J, "New loliolide derivatives from the brown alga Undaria pinnatifida" 65 : 57-58, 2002

      9 Tak, P. P., "NF-κB : A key role in inflammatory disease" 107 : 7-11, 2001

      10 Olivera, A., "Mast cells signal their importance in health and disease" 142 : 381-393, 2018

      11 Galli, S. J., "Mast cells as “tunable”effector and immunoregulatory cells: Recent advances" 23 : 749-786, 2005

      12 Harvima, I.T, "Mast cells as regulators of skin inflammation and immunity" 91 : 644-650, 2011

      13 Caughey, G, H, "Mast cell proteases as pharmacological targets" 778 : 44-55, 2016

      14 김철환, "LPS로 유도된 RAW 264.7 대식세포의 염증반응에서 MAPK 신호경로 조절을 통한 지칭개 에탄올 추출물의 항염증 효과" 한국자원식물학회 34 (34): 23-30, 2021

      15 Martin, R. A., "Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease" 48 : 655-664, 2013

      16 Hawiger, J, "Innate immunity and inflammation : A transcriptional paradigm" 23 : 99-109, 2001

      17 Gilmore, T. D., "Inhibition of NF-κBsignaling as a strategy in disease therapy" 349 : 245-263, 2011

      18 남선영, "Inhibition of IL-32 Signaling by Bamboo Salt Decreases Pro-Inflammatory Responses in Cellular Models of Allergic Rhinitis" 한국식품영양과학회 17 (17): 939-948, 2014

      19 Jennifer, C. F., "Imaging the role of inflammation in mood and anxiety-related disorders" 16 : 533-558, 2018

      20 Birrell, M. A., "Ikappa-B kinase-2inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma" 172 : 962-971, 2005

      21 Jemima, E. A., "Functional characterization of histamine H4 receptor on human mast cells" 62 : 19-28, 2014

      22 Modena, B. D., "Emerging concepts : Mast cell involvement in allergic diseases" 174 : 98-121, 2016

      23 Yoshinaga, K., "Effects of Undaria pinnatifida (Wakame) on postprandial glycemia and Insulin Levels in Humans: a Randomized Crossover Trial" 74 (74): 461-467, 2019

      24 Fedenko, E. S., "Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals" 2 : 120-124, 2011

      25 Trefzer, U., "Cytokine and anti-cytokine therapy in dermatology" 3 : 733-743, 2003

      26 Ogata, H, "Cytokine and anti-cytokine therapies for inflammatory bowel disease" 9 : 1107-1113, 2003

      27 Kim, H. Y., "Atractylone, an active constituent of KMP6, attenuates allergic inflammation on allergic rhinitis in vitro and in vivo models" 8 : 121-132, 2016

      28 Sakamoto, T., "Anti-inflammatory properties of cilostazol : Its interruption of DNA binding activity of NF-kappaB from the Toll-like receptor signaling pathways" 62 : 120-131, 2018

      29 Nam S. Y, "Anti-inflammatory effects of a traditional Korean medicine : Ojayeonjonghwan" 55 : 1856-1862, 2017

      30 Gadaleta, R. M., "Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine" 1812 : 851-858, 2011

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 재인증평가 신청대상 (재인증)
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2012-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2008-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2007-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2006-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2003-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.77 0.77 0.77
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.74 0.67 1.157 0.27
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼